| human | Q5 |
| P496 | ORCID iD | 0000-0002-2770-8223 |
| P69 | educated at | Yale University | Q49112 |
| University of Wisconsin–Madison | Q838330 | ||
| Rush University Medical Center | Q1535116 | ||
| University of Chicago Medical Center | Q7895258 | ||
| P108 | employer | University of Wisconsin–Madison | Q838330 |
| P734 | family name | Stein | Q2339506 |
| Stein | Q2339506 | ||
| Stein | Q2339506 | ||
| P735 | given name | James | Q677191 |
| James | Q677191 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q37641432 | 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis |
| Q33558799 | 25-hydroxyvitamin D and parathyroid hormone levels do not predict changes in carotid arterial stiffness: the Multi-Ethnic Study of Atherosclerosis |
| Q58375474 | A Unique Left-to-Right Shunt Characterized by Multimodality Cardiac Imaging |
| Q40597538 | A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy |
| Q34269157 | A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk |
| Q36063551 | A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness |
| Q35637475 | A randomized controlled trial of the effects of vitamin D supplementation on arterial stiffness and aortic blood pressure in Native American women |
| Q52974278 | A semiautomated ultrasound border detection program that facilitates clinical measurement of ultrasound carotid intima-media thickness. |
| Q37293485 | ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. |
| Q34883156 | ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents |
| Q58375412 | ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain |
| Q34971421 | ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co |
| Q54128081 | ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, Am |
| Q57154147 | ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats |
| Q57154140 | ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats⁎⁎The findings and conclusions in this report are those of the Conference participants and do not necessarily reflect the official position of the Amer |
| Q57072671 | AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update |
| Q55055148 | AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. |
| Q46469170 | Advanced lipoprotein testing does not improve identification of subclinical atherosclerosis in young adults: the Bogalusa Heart Study |
| Q35218394 | Ambulatory activity associations with cardiovascular and metabolic risk factors in smokers |
| Q35903513 | American Society of Echocardiography recommendations for use of echocardiography in clinical trials |
| Q58375407 | An Abbreviated Carotid Intima-Media Thickness Scanning Protocol to Facilitate Clinical Screening for Subclinical Atherosclerosis |
| Q40181922 | Antiretroviral initiation is associated with increased skeletal muscle area and fat content |
| Q40076502 | Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants |
| Q27026486 | Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? |
| Q39730734 | Association between air pollution and coronary artery calcification within six metropolitan areas in the USA (the Multi-Ethnic Study of Atherosclerosis and Air Pollution): a longitudinal cohort study |
| Q40379141 | Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis |
| Q27332462 | Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis |
| Q35637447 | Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis |
| Q35124939 | Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial |
| Q58375463 | Benefits of cholesterol screening and therapy for primary prevention of cardiovascular disease: a new paradigm |
| Q58375465 | Benefits of lipid-lowering therapy |
| Q38601598 | Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis |
| Q36676379 | Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s |
| Q36958022 | Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals |
| Q35034349 | Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations |
| Q93000001 | Brachial artery intima-media thickness and grayscale texture changes in patients with peripheral artery disease receiving supervised exercise training in the PROPEL randomized clinical trial |
| Q60614557 | CORONARY ARTERY CALCIUM SCORE IS SUPERIOR TO CAROTID PLAQUE SCORE FOR PREDICTING CARDIOVASCULAR DISEASE EVENTS: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS |
| Q36473298 | Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition |
| Q58375390 | Cardiovascular Disease Risk Prediction Measures |
| Q58375409 | Cardiovascular Risks of Antiretroviral Therapy |
| Q58375443 | Cardiovascular disease prevention |
| Q26851934 | Cardiovascular risk and dyslipidemia management in HIV-infected patients |
| Q45418720 | Cardiovascular risk in patients with human immunodeficiency virus infection: incomplete data |
| Q36366369 | Carotid Artery Imaging: Insights Into Inflammation and Cardiovascular Disease Risk in Patients With HIV Infection |
| Q30398883 | Carotid Artery Longitudinal Displacement, Cardiovascular Disease and Risk Factors: The Multi-Ethnic Study of Atherosclerosis |
| Q58375381 | Carotid Intima-Media Thickness and Cardiovascular Disease Risk Prediction |
| Q58375401 | Carotid Intima-Media Thickness, Plaques, and Cardiovascular Disease Risk |
| Q58375398 | Carotid Intima–Media Thickness and Cardiovascular Events |
| Q92725777 | Carotid artery displacement and cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis |
| Q47225331 | Carotid artery ultrasound texture, cardiovascular risk factors, and subclinical arterial disease: the multi-ethnic study of atherosclerosis (MESA). |
| Q40507986 | Carotid intima-media thickness and vascular age: you are only as old as your arteries look |
| Q44892304 | Carotid intima-media thickness progression and cardiovascular disease risk |
| Q50900855 | Carotid intima-media thickness testing by non-sonographer clinicians: the office practice assessment of carotid atherosclerosis study. |
| Q58375402 | Carotid ultrasound in children: a window to arterial ageing |
| Q43869313 | Cerivastatin and endothelial function in elderly patients with diabetes mellitus. |
| Q40620689 | Change in Neighborhood Characteristics and Change in Coronary Artery Calcium: A Longitudinal Investigation in the MESA (Multi-Ethnic Study of Atherosclerosis) Cohort |
| Q43232557 | Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy |
| Q36078749 | Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir |
| Q35974422 | Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s |
| Q37305570 | Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s |
| Q40632652 | Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s |
| Q92681040 | Changes in carotid artery structure with smoking cessation |
| Q54256985 | Changes in plasma RANKL-osteoprotegerin in a Prospective, Randomized Clinical trial of Initial Antiviral Therapy: A5260s. |
| Q40529577 | Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s |
| Q47928299 | Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease |
| Q34994233 | Clinical cardiac manifestations of HIV infection: a review of current literature. |
| Q44108194 | Clinical trials testing the homocysteine hypothesis |
| Q58375425 | Closing the Cholesterol Treatment Gap |
| Q89801578 | Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial |
| Q34238363 | Combined effects of sleep disordered breathing and metabolic syndrome on endothelial function: the Wisconsin Sleep Cohort study |
| Q38786435 | Comparing Arterial Function Parameters for the Prediction of Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q41102621 | Comparison of Carotid Plaque Score and Coronary Artery Calcium Score for Predicting Cardiovascular Disease Events: The Multi-Ethnic Study of Atherosclerosis |
| Q58375466 | Comparison of Estimates of Right Atrial Pressure by Physical Examination and Echocardiography in Patients With Congestive Heart Failure and Reasons for Discrepancies |
| Q36116238 | Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study |
| Q27340038 | Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis |
| Q30544299 | Coronary flow velocity changes in response to hypercapnia: assessment by transthoracic Doppler echocardiography |
| Q35478435 | Coronary heart disease incidence in sleep disordered breathing: the Wisconsin Sleep Cohort Study |
| Q36016861 | Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals |
| Q58375470 | Cost and appropriateness of radionuclide exercise stress testing by cardiologists and non-cardiologists |
| Q28391989 | DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis |
| Q58375446 | Diagnostic utility of cardiac troponin-I levels in patients with suspected pulmonary embolism |
| Q46965402 | Distribution and predictors of carotid intima-media thickness in young adults |
| Q46884929 | Does detection of carotid plaque affect physician behavior or motivate patients? |
| Q35085613 | Dyslipidemia in the era of HIV protease inhibitors |
| Q58375438 | Echocardiographic diagnosis and catheter treatment of hypotension caused by cor triatriatum dexter |
| Q52252082 | Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. |
| Q66670780 | Effect modification of airborne particulate matter on subclinical atherosclerosis by risk factor burden: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q46437920 | Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial |
| Q52945128 | Effect of cardiac cycle on ultrasound assessment of endothelial function. |
| Q58375450 | Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease |
| Q36956948 | Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death |
| Q36777034 | Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial |
| Q30368951 | Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study. |
| Q99555742 | Effects of Smoking and Smoking Cessation on the Intestinal Microbiota |
| Q35755863 | Effects of an office-based carotid ultrasound screening intervention |
| Q36622711 | Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study |
| Q45075951 | Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults |
| Q40518202 | Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors |
| Q46674409 | Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease |
| Q28730693 | Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial |
| Q34165917 | Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial |
| Q35033214 | Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial |
| Q34117383 | Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers |
| Q102139816 | Effects of ultrasound technology advances on measurement of carotid intima-media thickness: A review |
| Q58375476 | Efficacy of low-density-lipoprotein lowering with statins |
| Q34692970 | Electrocardiographic changes associated with smoking and smoking cessation: outcomes from a randomized controlled trial |
| Q58375420 | Endothelial Function in Patients with HIV Infection |
| Q37016796 | Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. |
| Q36087108 | Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation |
| Q36522654 | Factors associated with iohexol-based glomerular filtration rate slope over 36 months in HIV-negative and HIV-positive individuals |
| Q33820060 | Gender differences in acute myocardial infarction: the University of Wisconsin experience. |
| Q38387364 | GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation |
| Q58375437 | Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the |
| Q37055020 | HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative |
| Q58375384 | HIV and Atherosclerosis: Moving From Associations to Mechanisms and Interventions |
| Q35830731 | HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function |
| Q40089833 | HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress |
| Q40546493 | HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease |
| Q44186788 | Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults |
| Q52612811 | Hepatocyte growth factor is associated with progression of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q55056849 | High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis). |
| Q38386755 | Histopathologic Validation of Grayscale Carotid Plaque Characteristics Related to Plaque Vulnerability. |
| Q41627507 | Homocysteine: a new risk factor for atherosclerosis |
| Q58375461 | Hyperhomocysteinemia and Atherosclerotic Vascular Disease |
| Q31105298 | Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002. |
| Q58375459 | Improved risk stratification in unstable angina: Identification of patients at low risk for in-hospital cardiac events by admission echocardiography |
| Q43862814 | Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia. |
| Q58375478 | Incidence and results of arterial complications among 16,350 patients undergoing cardiac catheterization |
| Q46626279 | Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study |
| Q40571696 | Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors |
| Q58375408 | Increases in Central Aortic Impedance Precede Alterations in Arterial Stiffness Measures in Type 1 Diabetes |
| Q40606274 | Inflammation and Arterial Injury in Individuals With Human Immunodeficiency Virus Infection |
| Q58375394 | Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection |
| Q58375416 | Is the ankle-brachial index a useful screening test for subclinical atherosclerosis in asymptomatic, middle-aged adults? |
| Q28392474 | Late-Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort |
| Q58375406 | Left Atrial Volume Is Associated with Inflammation and Atherosclerosis in Patients with Kidney Disease |
| Q37086312 | Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. |
| Q41497016 | Lipoprotein Lp(a) excess and coronary heart disease |
| Q37134775 | Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation |
| Q34765654 | Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation |
| Q34784907 | Long-term effects of carotid screening on patient outcomes and behaviors |
| Q35947698 | Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial |
| Q49213720 | Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk |
| Q30564047 | Longitudinal effects of a decade of aging on carotid artery stiffness: the multiethnic study of atherosclerosis |
| Q30249076 | Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin? |
| Q36020617 | Managing cardiovascular risk in patients with HIV infection |
| Q37610700 | Microbial translocation and metabolic and body composition measures in treated and untreated HIV infection |
| Q36225329 | Minimal nocturnal oxygen saturation predicts future subclinical carotid atherosclerosis: the Wisconsin sleep cohort |
| Q37204095 | Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation |
| Q46814043 | Mitral annular calcification is associated with reduced left ventricular function and inflammation in patients with chronic kidney disease |
| Q46460706 | National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002. |
| Q58375435 | Noninvasive assessment of coronary flow reserve by echocardiography: technical considerations |
| Q45359098 | Nutritional therapy to prevent dyslipidemia in patients starting antiretroviral therapy for human immunodeficiency virus |
| Q34657248 | Obstructive sleep apnea is associated with future subclinical carotid artery disease: thirteen-year follow-up from the Wisconsin sleep cohort |
| Q23915853 | Occupational characteristics and the progression of carotid artery intima-media thickness and plaque over 9 years: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q46847969 | Outcomes in 45 patients with statin-associated myopathy |
| Q39414284 | Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection |
| Q34674223 | Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial |
| Q58375352 | Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance |
| Q37358898 | Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease |
| Q50077478 | Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression: The Multi-Ethnic Study of Atherosclerosis |
| Q44145192 | Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection |
| Q51479267 | Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. |
| Q30596511 | Predictors of carotid thickness and plaque progression during a decade: the Multi-Ethnic Study of Atherosclerosis |
| Q34694448 | Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study |
| Q58375403 | Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients |
| Q30409726 | Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study |
| Q40473676 | Progression of Carotid Arterial Stiffness With Treatment of Hypertension Over 10 Years: The Multi-Ethnic Study of Atherosclerosis. |
| Q28394334 | Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) |
| Q58375456 | Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease |
| Q46222321 | Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus |
| Q35227434 | Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis |
| Q64239396 | Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial |
| Q53457837 | Radiation and coronary calcium screening. |
| Q42663508 | Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view |
| Q46989770 | Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002). |
| Q50054016 | Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV. |
| Q34404759 | Relationship between microbial translocation and endothelial function in HIV infected patients |
| Q37694371 | Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer's disease |
| Q36208676 | Relationships between sleep apnea, cardiovascular disease risk factors, and aortic pulse wave velocity over 18 years: the Wisconsin Sleep Cohort |
| Q35746993 | Risk factors for subclinical carotid atherosclerosis among current smokers |
| Q58375404 | Risk of myocardial infarction and nucleoside analogues |
| Q36528526 | Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148. |
| Q36673883 | Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy |
| Q35007858 | Sex differences in predictors of longitudinal changes in carotid artery stiffness: the Multi-Ethnic Study of Atherosclerosis |
| Q34079197 | Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy. |
| Q58375413 | Should advanced lipoprotein testing be used in clinical practice? |
| Q46843171 | Skin cholesterol content identifies increased carotid intima-media thickness in asymptomatic adults |
| Q33706475 | Smoking cessation and the risk of diabetes mellitus and impaired fasting glucose: three-year outcomes after a quit attempt |
| Q43865000 | Smoking cessation, but not smoking reduction, reduces plasma homocysteine levels. |
| Q33573077 | Smoking intensity and lipoprotein abnormalities in active smokers |
| Q36812073 | State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary |
| Q36932583 | Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA) |
| Q43540123 | Tachyphylaxis and statin drugs |
| Q36430090 | Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study |
| Q34022153 | The Effects of Sleep-Disordered Breathing on Arterial Stiffness are Modulated by Age |
| Q43818848 | The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia |
| Q34286911 | The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. |
| Q58375471 | Thrombus Associated With Mitral Valve Calcification |
| Q33665220 | Transesophageal echocardiography for the evaluation and management of patients with cerebral ischemia. |
| Q58375458 | Transient effusive-constrictive pericarditis due to chemotherapy |
| Q35706822 | Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial |
| Q30383396 | Treatment of Obstructive Sleep Apnea in Young and Middle-Aged Adults: Effects of Positive Airway Pressure and Compliance on Arterial Stiffness, Endothelial Function, and Cardiac Hemodynamics. |
| Q47987148 | Treatment of severe hypertriglyceridemia lowers plasma viscosity |
| Q34657896 | Trends in low-density lipoprotein cholesterol goal achievement in high risk United States adults: longitudinal findings from the 1999-2008 National Health and Nutrition Examination Surveys |
| Q36875816 | Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection |
| Q30370535 | Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation? |
| Q36555908 | Ultrasound-detected carotid plaque as a predictor of cardiovascular events |
| Q46807082 | Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis |
| Q58375419 | Use of Carotid Intima-Media Thickness and Vascular Age to Modify Cardiovascular Risk Prediction |
| Q58375415 | Use of Hand-held Ultrasound by a Nonsonographer Clinician to Measure Carotid Intima-Media Thickness |
| Q34748094 | Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V |
| Q37419330 | Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the American Society of Echocardiography consensus statement |
| Q43678570 | Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction |
| Q46688227 | Usefulness of increased skin cholesterol to identify individuals at increased cardiovascular risk (from the Predictor of Advanced Subclinical Atherosclerosis study). |
| Q48796282 | Utility of TEE for the evaluation of cerebral ischemia of uncertain origin |
| Q51952727 | Validation of a carotid intima-media thickness border detection program for use in an office setting. |
| Q45009507 | Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment. |
| Q36102556 | Vitamin D levels and markers of arterial dysfunction in HIV |
| Q43808920 | Wine and your heart |
| Q34019246 | β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol |
Search more.